Trial Profile
Insulin action and hypertension: effects of hyperaldosteronism and its treatment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2021
Price :
$35
*
At a glance
- Drugs Eplerenone (Primary) ; Doxazosin
- Indications Essential hypertension
- Focus Pharmacodynamics
- 15 Aug 2010 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 08 Oct 2008 New trial record.